RKV.V · Rakovina Therapeutics Inc.
Canada · RS rating 81 · As of 2026-10-14
| Price | 0.22 CAD |
|---|---|
| 1-day change | +2.3% |
| RS rating (overall / 1M / 3M / 12M) | 81 / 29 / 97 / 26 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 42 / 41 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | +12.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +29.7% |
| Market cap (USD) | $3.9M |